AHA 2024 Archives - Medical Conferences

Home > Cardiology > AHA 2024

American Heart Association 16–18 November 2024 Chicago, IL, USA

Featured articles

AHA 2024 Highlights Podcast

Presented By

Robert van den Heuvel, Medicom

Conference

AHA 2024

4 December 2024 12:31

SUMMIT: Tirzepatide reduces cardiovascular events in HFpEF plus obesity

Presented By

Prof. Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, SUMMIT

Conference

AHA 2024

Type

News article

18 November 2024 12:25

Online First

VANISH2: Antiarrhythmic drug therapy or catheter ablation in MI plus VT?

Presented By

Dr John Sapp, Queen Elizabeth II Health Sciences Centre, Canada

Trial

Phase 4, VANISH2

Conference

AHA 2024

Type

News article

20 November 2024 16:01

KRAKEN: Encouraging phase 2 results of Lp(a) lowering muvalaplin

Presented By

Prof. Stephen Nicholls, University of Melbourne, Australia

Trial

Phase 2, KRAKEN

Conference

AHA 2024

Type

News article

20 November 2024 15:59

Comparing dual antihypertensive combination therapies in a South Asian population

Presented By

Prof. Dorairaj Prabhakaran, Centre for Chronic Disease Control, India

Trial

TOPSPIN

Conference

AHA 2024

Type

News article

20 November 2024 15:57

Novel small-interfering RNA effectively reduced Lp(a) in phase 2

Presented By

Prof. Steven Nissen, Cleveland Clinic, USA

Trial

Phase 2

Conference

AHA 2024

Type

News article

20 November 2024 15:55

OPTION: LAAC over OAC after ablation in patients with AF and increased stroke risk

Presented By

Prof. Oussama Wazni, Cleveland Clinic, USA

Trial

OPTION

Conference

AHA 2024

Type

News article

20 November 2024 15:53

CLEAR SYNERGY: Can routine spironolactone improve post-MI outcomes?

Presented By

Prof. Sanjit Jolly, McMaster University, Canada

Trial

CLEAR SYNERGY

Conference

AHA 2024

Type

News article

19 November 2024 16:38

Head-to-head: Cryoballoon vs radiofrequency ablation in persistent AF

Presented By

Dr Kengo Kusano, National Cerebral and Cardiovascular Center, Japan

Trial

CRRF-PeAF

Conference

AHA 2024

Type

News article

19 November 2024 16:34

Reconditioned pacemakers may save lives in low/middle-income countries

Presented By

Dr Thomas Crawford, University of Michigan, USA

Trial

My Heart Your Heart

Conference

AHA 2024

Type

News article

19 November 2024 16:32

ARREST-AF: The true impact of risk factor management on AF recurrence after ablation

Presented By

Prof. Rajeev Pathak, University of Adelaide, Australia

Trial

ARREST-AF

Conference

AHA 2024

Type

News article

19 November 2024 16:29

REALIZE-K: MRA treatment optimisation in HFrEF plus hyperkalaemia

Presented By

Prof. Mikhail Kosiborod, University of Missouri, USA

Trial

REALIZE-K

Conference

AHA 2024

Type

News article

19 November 2024 16:27

SUMMIT: Tirzepatide reduces cardiovascular events in HFpEF plus obesity

Presented By

Prof. Milton Packer, Baylor University Medical Center, USA

Trial

Phase 3, SUMMIT

Conference

AHA 2024

Type

News article

18 November 2024 12:25

BPROAD: Intensive or standard BP treatment strategy in type 2 diabetes?

Presented By

Prof. Guang Ning, Shanghai Jiao Tong University School of Medicine, China

Trial

BROAD

Conference

AHA 2024

Type

News article

18 November 2024 12:22

Promising results for CRISPR-based therapy in ATTR-CM

Presented By

Prof. Marianna Fontana, University College London, UK

Trial

Phase 1

Conference

AHA 2024

Type

News article

18 November 2024 12:20

GLORIOUS: GLP-1 agonist did not meet primary endpoint in CABG

Presented By

Dr Sebastian Wiberg, Rigshospitalet, Denmark

Trial

GLORIOUS

Conference

AHA 2024

Type

News article

18 November 2024 12:18

ENBALV: Edoxaban or warfarin as anticoagulant after bioprosthetic valve replacement?

Presented By

Dr Chisato Izumi, National Cerebral and Cardiovascular Center, Japan

Trial

Phase 3, ENBALV

Conference

AHA 2024

Type

News article

18 November 2024 12:15

Featured articles

CONTENTS

Online First